Sinopharm Group Co. Ltd.
SHTDF | OTC
$2.15
+$0.14 (+6.97%)
Nov 2, 2026, 10:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 7.03B | 7.09B | 6.8B | 7.05B | 8.65B | 9.05B | 9.53B | 9.12B | 7.87B | 7.76B | 7.87B |
Depreciation & Amortization | 2.02B | 4.25B | 4.64B | 4.73B | 4.64B | 4.41B | 4.53B | 4.43B | 3.9B | 3.78B | 3.76B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -6.23B | -911.99M | -766.69M | n/a | 3.42B | 3.71B | 15.87B | 6.82B | -2.28B | 421.26M | 2.33B |
Other Non-Cash Items | 5.79B | -37.93B | -54.38B | -237.37M | 6.38B | 14.4B | 77.62B | 64.24B | 20.8B | 28.41B | 35.06B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 5.32B | -7.46B | 15.27B | n/a | -164.16M | -10.69B | -20.51B | 2.41B | -29.79B | -30.64B | -35.71B |
Operating Cash Flow | 20.16B | 12.05B | 18.43B | 11.55B | 19.51B | 17.17B | 11.93B | 20.96B | 2.78B | 9.31B | 10.98B |
Capital Expenditures | -1.47B | -1.55B | -2.11B | -2.46B | -2.26B | -1.96B | -1.66B | -1.82B | -2.15B | -2.07B | -2.1B |
Cash Acquisitions | 109.47M | 135.52M | 128.06M | n/a | -59.47M | 16.62M | -259.22M | -396.37M | -426.99M | -497.22M | -2.19B |
Purchase of Investments | -485K | -485K | n/a | n/a | 61.51M | 61.51M | 78.46M | 78.46M | n/a | n/a | n/a |
Sales Maturities Of Investments | 77.47M | 77.47M | n/a | n/a | -150.49M | -150.49M | -63.84M | -63.84M | n/a | n/a | n/a |
Other Investing Acitivies | -119.73M | 139.29M | -1.24B | -1.29B | -164.45M | 1.67B | 321.81M | -179.79M | 1.61B | 1.3B | 186.01M |
Investing Cash Flow | -884.69M | -1.3B | -3.24B | -3.75B | -2B | 223.09M | -1.39B | -2.18B | -964.24M | -1.27B | -4.11B |
Debt Repayment | -20.21B | -10.07B | 18.71B | 23.87B | -1.31B | -25.18B | -15.61B | -15.61B | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -2.09B | -4.23B | -4.86B | -5.06B | -4.9B | -2.56B | -2.63B | -2.63B | -2.15B | -2.15B | -1.86B |
Other Financial Acitivies | -3.24B | -2.53B | -37.11B | -36.1B | -1.18B | 20.09B | 13.49B | 14.71B | -1.89B | -12.54B | -9.99B |
Financial Cash Flow | -25.53B | -16.83B | -23.26B | -17.29B | -7.39B | -7.64B | -2.11B | -894.83M | -4.04B | -14.69B | -11.85B |
Net Cash Flow | -2.58B | 47.8B | -8.09B | n/a | 73.88B | 9.7B | 5.55B | 15.01B | -2.21B | -6.65B | -4.96B |
Free Cash Flow | 18.69B | 10.5B | 16.32B | 9.09B | 17.24B | 15.21B | 7.4B | 16.28B | 631.04M | 7.23B | 8.88B |
Adj. Free Cash Flow | 18.69B | 10.5B | 16.32B | 9.09B | 17.24B | 15.21B | 7.4B | 16.28B | 631.04M | 7.23B | 8.88B |
Maintenance CapEx | -2.99B | -4.01B | -3.13B | -2.46B | -1.97B | -1.39B | -1.99B | -1.99B | -1.32B | -1.39B | -788.47M |
Growth CapEx | -586.99M | n/a | -1.24B | -1.96B | -1.96B | -2.39B | -1.83B | -1.9B | -2.94B | -2.58B | -3.39B |
Owner Earnings | 35.6B | 19.59B | 34.8B | 26.26B | 29.47B | 36.75B | 12.73B | 28.28B | 12.45B | 19.07B | 14.72B |
Add to Watchlist
Select watchlists to add or remove SHTDF